BioSig Technologies, Inc. STEX Accounts payable and other current liabilities (Note 11)
Accounts payable and other current liabilities (Note 11) at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s accounts payable and other current liabilities (note 11).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s accounts payable and other current liabilities (note 11)?
- BioSig Technologies, Inc. (STEX) reported accounts payable and other current liabilities (note 11) of $3.18M in Q1 2026.
- How has BioSig Technologies, Inc.'s accounts payable and other current liabilities (note 11) changed year-over-year?
- BioSig Technologies, Inc.'s accounts payable and other current liabilities (note 11) increased by 110.9% year-over-year, from $1.51M to $3.18M.
- What is the long-term trend for BioSig Technologies, Inc.'s accounts payable and other current liabilities (note 11)?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s accounts payable and other current liabilities (note 11) has grown at a -9.0% compound annual growth rate (CAGR), from $4.72M to $2.95M.